Viewing StudyNCT00093002

Bugs

eRecord

Ignite Creation Date: 2024-05-05 @ 11:36 AM

Last Modification Date: 2024-10-26 @ 9:10 AM

Study NCT ID: NCT00093002

Status: COMPLETED

Last Update Posted: 2008-06-12

First Post: 2004-09-28

Brief Title: Fulvestrant FASLODEX as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

Sponsor: AstraZeneca

Organization: AstraZeneca

Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions:

Name

Breast Cancer

Keywords:

Name	View

invasive breast cancer	View
Early Breast Cancer	View
neoadjuvant therapy	View
hormonal treatment	View
newly diagnosed breast cancer	View
Estrogen Receptor Positive Breast Cancer	View
treatment naïve	View
neoadjuvant treatment	View
neoadjuvant setting	View